Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01498692 · ClinicalTrials.gov registry record · NA
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels
A NA study of Coronary Artery Disease, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 94
- Enrollment target
- 20
- Study locations
NCT01498692: Completed NA study of Coronary Artery Disease, sponsored by Boston Scientific Corporation.
NCT01498692 is a NA study of Coronary Artery Disease that has completed, run by Boston Scientific Corporation. The registered enrollment target is 94 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (93% lower). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01498692, a NA study of Coronary Artery Disease, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the PROMUS Element™ Everolimus-Eluting Coronary Stent System for the treatment of patients with up to 2 de novo atherosclerotic coronary artery lesions. The lesions can be located in vessels that are smaller than average-sized.
Primary Outcome
Defined as any ischemia-driven revascularization of the target lesion, myocardial infarction (Q-wave and non-Q-wave) related to the target vessel, or cardiac death related to the target vessel. The primary analysis set for the non-inferiority testing of the primary endpoint is the per-protocol analysis set. All randomized participants who received their assigned treatment are included in the per-protocol analysis set.
Conditions Studied
Interventions
- DEVICE PROMUS Element Coronary Stent System
Study Locations (20)
Other
- Monash Medical Centre - Clayton
- Ziekenhuis Oost Limburg - Genk
- UZ Gasthuisberg - Leuven
- Clinique Pasteur - Toulouse
Florida
- Mediquest Research at Munroe Regional Medical Center - Ocala
- Florida Hospital - Orlando
North Carolina
- Moses H. Cone Memorial Hospital/LeBauer Cardiovascular Research Foundation - Greensboro
- Wake Medical Center - Raleigh
Ohio
- Lindner Center for Research and Education at The Christ Hospital - Cincinnati
- Ohio Health Research and Innovation Institute - Columbus
Texas
- Baylor Heart & Vascular Hospital - Dallas
- TexSAn Heart Hospital - San Antonio
California
- Bakersfield Memorial Hospital - Bakersfield
Illinois
- St. John's Hospital - Springfield
Kentucky
- Jewish Hospital & St. Mary's Healthcare - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2009-02 |
| Est. Completion | 2015-05 |
| Phase | NA |
What the finished NCT01498692 record still lists
NCT01498692 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which PROMUS Element Coronary Stent System is the first listed.
NCT01498692 names 20 study sites across 13 states, led by Other, Florida, North Carolina.
Frequently Asked Questions
What is clinical trial NCT01498692 about?
NCT01498692 is a clinical study titled "The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels". The purpose of this study is to evaluate the safety and effectiveness of the PROMUS Element™ Everolimus-Eluting Coronary Stent System for the treatment of patients with up to 2 de novo atherosclerotic coronary artery lesions. The lesions can be located in vessels that are smaller than average-sized.
What is the current status of trial NCT01498692?
This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2009-02. Estimated completion is 2015-05.
What conditions does trial NCT01498692 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
What interventions are being tested in trial NCT01498692?
The interventions under investigation include: PROMUS Element Coronary Stent System (DEVICE).
Who is sponsoring clinical trial NCT01498692?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01498692 being conducted?
This trial has 20 study locations across California, Florida, Illinois, Kentucky, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01498692's enrollment target sits among peer trials
94 152nd of 219 higher than 68 of 219 other Coronary Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
-
Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule Treatment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia